However, we now know that ILC3s, though fewer in number, are prolific producers of IL-17 and/or IL-22, as well as other important lung cytokines such as GM-CSF, and thus have the capacity to drive inflammation or repair in a number of infectious and autoimmune diseases (97–100). This evidence concerns the gene IL22 and autoimmune disease.